Results 181 to 190 of about 14,264,655 (329)
The Placebo Effect in Chronic Thromboembolic Pulmonary Hypertension Trials: A Systematic Review and Meta-Analysis. [PDF]
Caldeira D+5 more
europepmc +1 more source
Myths and Truths about Placebo Effect in Rehabilitation for Musculoskeletal Pain. [PDF]
Iolascon G, Moretti A.
europepmc +1 more source
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek+7 more
wiley +1 more source
Placebo Effect Sizes in Clinical Trials of Knee Osteoarthritis Using Intra-Articular Injections of Biologic Agents. [PDF]
Borst JM+5 more
europepmc +1 more source
Response to: Real effect vs placebo effect. [PDF]
Vgontzas AN+2 more
europepmc +1 more source
Objectives Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicentre, randomised, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad
Jia Sun+19 more
wiley +1 more source
Caffeine Placebo Effect in Sport and Exercise: A Systematic Review. [PDF]
Vega-Muñoz A+5 more
europepmc +1 more source
[What can psychotherapy learn from the placebo effect?] [PDF]
Rief W.
europepmc +1 more source
Vitamin B12 Treatment Normalizes Metabolic Markers But Has Limited Clinical Effect: A Randomized Placebo-controlled Study [PDF]
Anne‐Mette Hvas+2 more
openalex +1 more source
Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi+6 more
wiley +1 more source